{"cluster": 16, "subcluster": 12, "abstract_summ": "Drugs that interact with the renin-angiotensin system may impact ACE2 expression and COVID-19 pathogenesis; however, the magnitude and direction of these effects are unknown at this time.It has been hypothesized that use of renin-angiotensin system (RAS) inhibiting medications in patients with hypertension, increases the expression of ACE2 and thereby increases the risk of COVID-19 infection and severe outcomes or death.However, the effect of RAS-inhibition on ACE2 expression in human tissues of key relevance to blood pressure regulation and COVID-19 infection has not previously been reported.In the renin-angiotensin system (RAS), ACE2 has counter-regulatory functions against the classical effector peptide angiotensin II, for example in blood pressure regulation and cardiovascular remodeling.We show no association between renal expression of ACE2 and either hypertension or common types of RAS inhibiting drugs.", "title_summ": "Role of brain renin angiotensin system in neurodegeneration: An updateHypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidneyRelationship Between ACE2 and Other Components of the Renin-Angiotensin SystemRenin-Angiotensin-System (RAS) und COVID-19 \u2013 Zur Verordnung von RAS-BlockernAn update on ACE2 amplification and its therapeutic potential", "title_abstract_phrases": "Drugs that interact with the renin-angiotensin system may impact ACE2 expression and COVID-19 pathogenesis; however, the magnitude and direction of these effects are unknown at this time.Hypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidneyAngiotensin converting enzyme 2 (ACE2) is the cellular entry point for severe acute respiratory syndrome coronavirus (SARS-CoV-2) - the cause of COVID-19 disease.It has been hypothesized that use of renin-angiotensin system (RAS) inhibiting medications in patients with hypertension, increases the expression of ACE2 and thereby increases the risk of COVID-19 infection and severe outcomes or death.An update on ACE2 amplification and its therapeutic potentialThe renin angiotensin system (RAS) plays an important role in the pathogenesis of variety of diseases.However, the effect of RAS-inhibition on ACE2 expression in human tissues of key relevance to blood pressure regulation and COVID-19 infection has not previously been reported."}